We are live on ! Find out more
JAFL

Jay A. Fishman Ltd Portfolio holdings

AUM $1.12B
1-Year Est. Return 32.75%
This Fund
S&P 500
This Quarter Est. Return
+14.41%
1 Year Est. Return
+32.75%
3 Year Est. Return
+106.85%
5 Year Est. Return
+144.56%
10 Year Est. Return
+606.28%
AUM
$825M
AUM Growth
+$42.3M
Cap. Flow
-$52.2M
Cap. Flow %
-6.32%
Top 10 Hldgs %
67.92%
Holding
103
New
10
Increased
17
Reduced
46
Closed
5

Top Buys

Rank Stock Value
1
CMA
Comerica
CMA
+$10.8M
2
MRK icon
Merck
MRK
+$4.9M
3
ZTS icon
Zoetis
ZTS
+$2.56M
4
IEP icon
Icahn Enterprises
IEP
+$2.35M
5
LLY icon
Eli Lilly
LLY
+$1.61M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$16.5M
2
ABBV icon
AbbVie
ABBV
+$13.7M
3
JPM icon
JPMorgan Chase
JPM
+$6.14M
4
JNJ icon
Johnson & Johnson
JNJ
+$4.88M
5
BX icon
Blackstone
BX
+$3.25M

Sector Composition

Rank Sector Weight
1 Technology 34.33%
2 Financials 14.39%
3 Industrials 12.41%
4 Healthcare 12.15%
5 Consumer Discretionary 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TYRA icon
76
Tyra Biosciences
TYRA
$1.85B
$375K 0.05%
22,000
– –
IBB icon
77
iShares Biotechnology ETF
IBB
$9.44B
$373K 0.05%
2,940
– –
VFF icon
78
Village Farms International
VFF
$247M
$345K 0.04%
575,400
– –
TSM icon
79
TSMC
TSM
$2.07T
$340K 0.04%
3,367
– –
INTU icon
80
Intuit
INTU
$83.1B
$335K 0.04%
732
– –
EXP icon
81
Eagle Materials
EXP
$6.69B
$317K 0.04%
1,700
– –
PJT icon
82
PJT Partners
PJT
$4.36B
$280K 0.03%
4,026
-17,892
-82% -$1.24M
RIVN icon
83
Rivian
RIVN
$23.9B
$268K 0.03%
16,072
– –
MAR icon
84
Marriott International
MAR
$101B
$266K 0.03%
1,450
-250
-15% -$43.4K
SHYF
85
DELISTED
The Shyft Group
SHYF
$265K 0.03%
12,000
+2,000
+20% +$47K
XOM icon
86
ExxonMobil
XOM
$642B
$264K 0.03%
+2,462
New +$269K
EXR icon
87
Extra Space Storage
EXR
$31.3B
$260K 0.03%
1,750
– –
PG icon
88
Procter & Gamble
PG
$346B
$254K 0.03%
1,675
-126
-7% -$19K
CI icon
89
Cigna
CI
$77B
$247K 0.03%
+881
New +$229K
MSCI icon
90
MSCI
MSCI
$41.5B
$244K 0.03%
520
– –
GS icon
91
Goldman Sachs
GS
$309B
$228K 0.03%
+706
New +$232K
DOW icon
92
Dow Inc
DOW
$20.8B
$213K 0.03%
+4,000
New +$213K
VBR icon
93
Vanguard Small-Cap Value ETF
VBR
$37.3B
$203K 0.02%
+1,225
New +$193K
PMVP icon
94
PMV Pharmaceuticals
PMVP
$62.9M
$188K 0.02%
30,000
+5,000
+20% +$26.2K
RLAY icon
95
Relay Therapeutics
RLAY
$4.06B
$126K 0.02%
10,000
– –
TNGX icon
96
Tango Therapeutics
TNGX
$4.35B
$66.4K 0.01%
20,000
+10,000
+100% +$36K
GOEV
97
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$49.1K 0.01%
223
– –
BMY icon
98
Bristol-Myers Squibb
BMY
$128B
– –
-28,377
Closed -$1.97M
DOCU
99
DocuSign
DOCU
$10.1B
– –
-10,425
Closed -$608K
EEM icon
100
iShares MSCI Emerging Markets ETF
EEM
$28.6B
– –
-10,300
Closed -$406K
1 2 3
4
5

Similar funds

SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
PTC
Private Trust Company Cleveland, Ohio $1.12B AUM 21.35% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
EC
Estate Counselors Thiensville, Wisconsin $1.12B AUM 20.13% 1-Year Est. Return
AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return

Jay A. Fishman Ltd's Q2 2023 Portfolio in Review

As of Q2 2023, Jay A. Fishman Ltd held 103 positions worth $825M, up 5.4% from $783M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Jay A. Fishman Ltd withdrew a net $52.2M in Q2 2023, closing 5 positions and reducing 46 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Industrials.

Against the trend, Jay A. Fishman Ltd opened a new position in Comerica worth $11.4M.

  • Jay A. Fishman Ltd's largest Q2 2023 buy was Comerica: 268,325 shares worth $11.4M.
  • Jay A. Fishman Ltd added most to Merck in Q2 2023, an estimated $4.9M increase.
  • Jay A. Fishman Ltd's biggest Q2 2023 reduction was Apple, cutting an estimated $16.5M.
  • Jay A. Fishman Ltd fully exited Bristol-Myers Squibb in Q2 2023, selling an estimated $1.97M.
  • Jay A. Fishman Ltd's ten largest holdings make up 68% of its $825M portfolio in Q2 2023.
  • Jay A. Fishman Ltd opened 10 new positions and closed 5 in Q2 2023.
  • Jay A. Fishman Ltd's portfolio value rose 5.4% quarter-over-quarter to $825M.

Based on Jay A. Fishman Ltd's 13F filing for Q2 2023, filed 15 Aug 2023.